Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/11/2025

Clinical Features and Complications of Systemic Lupus Erythematosus

General Symptoms and Quality of Life

  • The American College of Rheumatology notes that quality of life is significantly impacted by disease activity, organ damage, and drug toxicity 1

Cardiovascular Manifestations

  • Patients with SLE have a markedly increased risk of premature atherosclerosis and cardiovascular disease that cannot be fully explained by traditional risk factors 1
  • Hypertension prevalence ranges from 11.5% to 75% in SLE patients 1
  • Dyslipidemia prevalence ranges from 11.5% to 75% in SLE patients 1

Neuropsychiatric Manifestations

  • Neuropsychiatric lupus can present with diverse manifestations including psychosis, seizures, acute confusional state, cranial or peripheral neuropathy, and transverse myelitis 4
  • Diagnostic work-up for neuropsychiatric symptoms should be similar to that in the general population presenting with the same symptoms 4

Important Associated Conditions

  • Antiphospholipid antibodies are present in a subset of patients and increase risk of thrombosis and pregnancy complications 4
  • The European League Against Rheumatism recommends specific management for patients with antiphospholipid syndrome, including consideration of low-dose aspirin for primary prevention 4

Increased Comorbidity Risk

  • Osteoporosis prevalence ranges from 4% to 24%, with vertebral fracture prevalence between 7.6% and 37% in SLE patients 1
  • Cancer incidence is increased, particularly hematological malignancies, cervical cancer, breast cancer, and lung cancer in SLE patients 5
  • Infection risk is elevated due to both disease-related immune dysregulation and immunosuppressive therapy in SLE patients 4

Clinical Pitfalls to Recognize

  • The clinical picture of SLE is extremely variable between patients and may change over time within the same patient 1
  • Disease activity must be distinguished from organ damage, drug toxicity effects, and intercurrent infections in SLE patients 1